These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
752 related articles for article (PubMed ID: 25217959)
1. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Canna SW; de Jesus AA; Gouni S; Brooks SR; Marrero B; Liu Y; DiMattia MA; Zaal KJ; Sanchez GA; Kim H; Chapelle D; Plass N; Huang Y; Villarino AV; Biancotto A; Fleisher TA; Duncan JA; O'Shea JJ; Benseler S; Grom A; Deng Z; Laxer RM; Goldbach-Mansky R Nat Genet; 2014 Oct; 46(10):1140-6. PubMed ID: 25217959 [TBL] [Abstract][Full Text] [Related]
2. A Novel Mutation in the NBD Domain of Wang L; Wen W; Deng M; Li Y; Sun G; Zhao X; Tang X; Mao H Front Immunol; 2021; 12():674808. PubMed ID: 34248956 [TBL] [Abstract][Full Text] [Related]
8. An inherited mutation in NLRC4 causes autoinflammation in human and mice. Kitamura A; Sasaki Y; Abe T; Kano H; Yasutomo K J Exp Med; 2014 Nov; 211(12):2385-96. PubMed ID: 25385754 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome. Barsalou J; Blincoe A; Fernandez I; Dal-Soglio D; Marchitto L; Selleri S; Haddad E; Benyoucef A; Touzot F Front Immunol; 2018; 9():2162. PubMed ID: 30319625 [TBL] [Abstract][Full Text] [Related]
10. Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis. Soares JL; Oliveira EM; Pontillo A Mult Scler Relat Disord; 2019 Apr; 29():26-34. PubMed ID: 30658261 [TBL] [Abstract][Full Text] [Related]
11. NLRC4 gain-of-function variant is identified in a patient with systemic lupus erythematosus. Wang Q; Ye X; Zheng W; Jin T; Zhou Y; Hu X; Zhou Q; Yu X Clin Immunol; 2023 Oct; 255():109731. PubMed ID: 37567492 [TBL] [Abstract][Full Text] [Related]
12. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome. Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788 [TBL] [Abstract][Full Text] [Related]
13. Novel NLRC4 Mutation Causes a Syndrome of Perinatal Autoinflammation With Hemophagocytic Lymphohistiocytosis, Hepatosplenomegaly, Fetal Thrombotic Vasculopathy, and Congenital Anemia and Ascites. Liang J; Alfano DN; Squires JE; Riley MM; Parks WT; Kofler J; El-Gharbawy A; Madan-Kheterpal S; Acquaro R; Picarsic J Pediatr Dev Pathol; 2017; 20(6):498-505. PubMed ID: 28403691 [TBL] [Abstract][Full Text] [Related]
14. A novel de novo NLRC4 mutation reinforces the likely pathogenicity of specific LRR domain mutation. Chear CT; Nallusamy R; Canna SW; Chan KC; Baharin MF; Hishamshah M; Ghani H; Ripen AM; Mohamad SB Clin Immunol; 2020 Feb; 211():108328. PubMed ID: 31870725 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of NLRC4 is critical for inflammasome activation. Qu Y; Misaghi S; Izrael-Tomasevic A; Newton K; Gilmour LL; Lamkanfi M; Louie S; Kayagaki N; Liu J; Kömüves L; Cupp JE; Arnott D; Monack D; Dixit VM Nature; 2012 Oct; 490(7421):539-42. PubMed ID: 22885697 [TBL] [Abstract][Full Text] [Related]
16. The autoinflammation-associated NLRC4 Eeckhout E; Asaoka T; Van Gorp H; Demon D; Girard-Guyonvarc'h C; Andries V; Vereecke L; Gabay C; Lamkanfi M; van Loo G; Wullaert A Front Immunol; 2023; 14():1272639. PubMed ID: 38090573 [TBL] [Abstract][Full Text] [Related]
19. HSC70 regulates cold-induced caspase-1 hyperactivation by an autoinflammation-causing mutant of cytoplasmic immune receptor NLRC4. Raghawan AK; Ramaswamy R; Radha V; Swarup G Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21694-21703. PubMed ID: 31597739 [TBL] [Abstract][Full Text] [Related]
20. SIRT3-mediated deacetylation of NLRC4 promotes inflammasome activation. Guan C; Huang X; Yue J; Xiang H; Shaheen S; Jiang Z; Tao Y; Tu J; Liu Z; Yao Y; Yang W; Hou Z; Liu J; Yang XD; Zou Q; Su B; Liu Z; Ni J; Cheng J; Wu X Theranostics; 2021; 11(8):3981-3995. PubMed ID: 33664876 [No Abstract] [Full Text] [Related] [Next] [New Search]